| feline panleukopenia virus | Oncolytic viruses (OVs) are emerging as powerful new therapeutic agents in cancer treatment, employing nature’s own agents to find and destroy malignant cells. After talimogene laherparepvec (T-Vec), the first OV, obtaining US Food and Drug Administration approval, more and more attention in OVs has been paid. Recent advances in viral retargeting, genetic editing, tracking strategies and OV-based gene therapy have the potential to broaden the applications of OV in cancer treatment. Thus, OV-based cancer therapy is becoming more popular for scientists, clinicians, and the public. So far, numerous OVs are being developed pre-clinically and clinically against many kinds of cancers, such as melanoma, pancreatic, breast cancers, glioblastoma, rectal cancer, lung cancer, pancreatic and hepatocellular carcinomas, etc. |
Forums
Explore the Forum Portal on Webyourself.eu, a vibrant community of web enthusiasts and professionals. Share insights, ask questions, and engage in enriching discussions that elevate your digital journey. Immerse yourself in the collective wisdom of the web, right here!
feline panleukopenia virus
| approved oncolytic viruses | The progress made in cancer therapy with oncolytic viruses in preclinical studies has further encouraged the transition into clinical trials. Based on the real-time tracking of the virotherapy research, Creative Biolabs also provide up-to-date information and trend analysis of clinical trials. |
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian